Barnet Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.63 M
About Barnet Pharmaceuticals
Barnet Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 May 2019 (Five years and nine months 6 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.63 M.
Vineeta Sharma, Soni Pandey, Praveen Kumar, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304DL2019PTC350295
- Company No.
350295
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Barnet Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vineeta Sharma  | Director | 06-Mar-2021 | Current |
| Soni Pandey | Director | 06-Mar-2021 | Current |
| Praveen Kumar | Director | 29-Oct-2021 | Current |
| Atul Sharma | Director | 21-May-2019 | Current |
| Shailendra Pandey | Director | 21-May-2019 | Current |
Financial Performance of Barnet Pharmaceuticals.
Enhance accessibility to Barnet Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Barnet Pharmaceuticals?
Unlock access to Barnet Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nishad Brothers Infrastructure Private LimitedPraveen Kumar is a mutual person
Charges (Loans)
₹2.63 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.26 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2022 | Hdfc Bank Limited | ₹2.02 M | Open |
| 23 Jan 2021 | Hdfc Bank Limited | ₹0.60 M | Open |
How Many Employees Work at Barnet Pharmaceuticals?
Unlock and access historical data on people associated with Barnet Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Barnet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Barnet Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.